Microbiology, Immunology & Infectious Diseases
Wednesday, December 14, 2016 | 6:00 PM - 8:30 PM
The New York Academy of Sciences
Researchers at Harvard T.H. Chan School of Public Health and SUNY Upstate Medical University present the results of a new study showing that employees in high-performing, green-certified buildings had higher cognitive function test scores than those in similarly high-performing buildings that were not green certified, even after controlling for other potential explanatory factors.
Tuesday, April 25, 2017 | 9:00 AM - 5:00 PM
Speakers: Peter S. Heeger (Icahn School of Medicine at Mount Sinai), V. Michael Holers (University of Colorado), Richard J. Quigg Jnr (University at Buffalo, The State University of New York), Peter A. Rice (University of Massachusetts Medical School), Bärbel Rohrer (Medical University of South Carolina), Beth Stevens (Boston Children's Hospital), Miles Nunn (Akari Therapeutics)
The complement system is the first line of defense against infection, however we have yet to capitalize on its therapeutic potential. This symposium will focus on novel insights into the complement pathway in a number of clinical disorders and offer.
May 15 - 17, 2017
Keynote Speaker: Vijay K. Kuchroo (Harvard Institutes of Medicine)
Learn about most recent advances in basic, translational, and clinical research on the rare, acquired disorder, Myasthenia Gravis, as well as implications of this research on a range of related autoimmune and neuromuscular diseases.
Thursday, November 3, 2016 | 9:00 AM - 5:00 PM
Speakers: Henrik Bjørn Nielsen (Clinical-Microbiomics A/S), Martin J. Blaser (New York University Langone Medical Center), Patrice D. Cani (Universite Catholique de Louvain, LDRI), Rachel Carmody (Harvard University), Stanley L. Hazen (Cleveland Clinic), Gerald I. Shulman (Yale University School of Medicine), Marion Soto (Joslin Diabetes Center, Harvard Medical School), and Dan Winer (University of Toronto)
The microbiome is emerging as an important regulator of health, and disease well beyond the digestive tract. This symposium will highlight recent research innovations and therapeutic applications from the microbiome with a focus on metabolic disease.
Thursday, September 8, 2016 | 9:00 AM - 5:00 PM
Speakers: Hans-Joachim Anders (University of Munich), John Cijiang He (Icahn School of Medicine at Mount Sinai), Matthias Kretzler (University of Michigan), Kevin V. Lemley (University of Southern California), Jochen Reiser (Rush University Medical Center), Myung K. Shin (Merck & Co. Inc.), Katalin Susztak (University of Pennsylvania), and Roger C. Wiggins (University of Michigan)
Accumulating evidence supports a role for renal inflammation and podocytopathy in pathogenesis and progression of chronic kidney disease. This symposium will delve into the mechanisms underlying this pathology.
Tuesday, June 28, 2016 | 8:00 AM - 5:30 PM
Keynote Speaker: Giancarlo Comi (Università Vita-Salute San Raffaele)
Explore novel and emerging treatments for multiple sclerosis, including biomarkers and MRI usage in disease diagnosis, prognosis, and monitoring.
Monday, June 13, 2016 | 10:00 AM - 3:30 PM
Speakers: Ruslan M. Medzhitov (Yale School of Medicine, Howard Hughes Medical Institute), Mauro Perretti (The William Harvey Research Institute, Queen Mary University of London), Charles N. Serhan (Brigham and Women's Hospital & Harvard Medical School), Lars Klareskog (Karolinska Institutet), and Kevin J. Tracey (The Feinstein Institute for Medical Research)
This symposium will honor Dr. Charles N. Serhan, the recipient of the 2016 Ross Prize in Molecular Medicine, for his important discoveries in identifying bioactive mediators and cellular pathways critical in the resolution of inflammatory diseases.
Edited by Xavier Rodó
(Catalan Institute for Climate Sciences)
This Annals issue discusses the latest research on the effects of climate and environmental changes on human health, including on the transmission of infectious diseases and the epidemiology of noncommunicable diseases.
Featured Speaker: Peter Godfrey-Faussett (UNAIDS)
Participants gathered at the New York Academy of Sciences to discuss one of the next frontiers in the HIV field: how NCDs and HIV interact, how they should be treated, and how policy needs to adapt to facilitate effective treatment for people living with NCDs.
Edited by Robert Giuli
(OESO Foundation) and Hans Gregersen
(Prince of Wales Hospital, Hong Kong)
This Annals issue is the first of two issues featuring review articles on topics related to esophageal function, dysfunction, and disease presented at the 13th OESO World Conference, with a focus on the Esophagiome.
Keynote Speakers: John Bienenstock (McMaster University, Canada) and Jeffrey Gordon (Washington University in St. Louis)
This eBriefing discusses the links between gut microbiota, diet, and health. It covers topics including the microbiome in development; microbiome interactions outside the gut; and the therapeutic potential of targeting the microbiome.